United States · Series D startup
2 rounds we have observed, with the 15 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$88Mraised across 2 rounds since 2003, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
U.S. Venture Partners
Mitsubishi UFJ Capital
CMEA Ventures
Vulcan Capital
Integra Ventures
Bear Stearns
Biogen IdecReported by freshnews.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Raven Biotechnologies's investors include U.S. Venture Partners, CMEA Ventures, Pequot Capital, Hambrecht & Quist Capital Management and Integra Ventures, and 10 more on record.
Raven Biotechnologies has raised $88M across 2 rounds since 2003.
Raven Biotechnologies's most recent round was a Series D of $48M in Oct 2005.
Its most recent round, $48M in Oct 2005, is also its largest on record.
Raven Biotechnologies's first round on record, in Jan 2003, was backed by U.S. Venture Partners, CMEA Ventures and Pequot Capital and 6 others.
Raven Biotechnologies's latest named round is a Series D, in Oct 2005.
Raven Biotechnologies is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·